Chunliu Mi1, Zhe Wang1, Ming Yue Li1, Zhi Hong Zhang1, Juan Ma1, Xuejun Jin1. 1. Key Laboratory of Natural Resources of Changbai Mountain and Functional Molecules, Ministry of Education, Molecular Medicine Research Center, College of Pharmacy, Yanbian University, Yanji, Jilin Province, China.
Abstract
BACKGROUND AND PURPOSE: IL-1β is a cytokine of critical importance in inflammatory, infectious and autoimmune diseases. Zinc finger protein 91 (ZFP91) has been reported to be involved in multiple biological processes. Here, we identified a previously unknown role for ZFP91 in the production of biologically active IL-1β and investigated the underlying mechanisms of its effects. EXPERIMENTAL APPROACH: In vitro, the underlying mechanisms of ZFP91 at inhibiting the expression of IL-1β were investigated by ELISA, RT-PCR, Western blotting, immunoprecipitation and immunofluorescence assays. In vivo, colitis was induced by giving 4% dextran sulfate sodium (DSS) p.o. in drinking water for 5 days. Peritonitis was induced by injecting 700 μg alum i.p. for 12 h. KEY RESULTS: ZFP91 activated the non-canonical caspase-8 inflammasome, which resulted in robust IL-1β secretion. Using an immunoprecipitation assay and immunofluorescence assay, we found that ZFP91 promoted the assembly of the non-canonical caspase-8 inflammasome complex. Moreover, ZFP91 enhanced the activation of ERK, p38 MAPK and JNK in macrophages. In addition, our data demonstrate that the synthesis of pro-IL-1β is dependent on activation of these MAPK signalling pathways. In vivo experiments, the symptoms and colonic inflammation associated with DSS-induced colitis were ameliorated in mice deficient in ZFP91. Furthermore, the inflammation in alum-induced peritonitis was also attenuated in mice deficient in ZFP91. CONCLUSIONS AND IMPLICATIONS: Our research describes a mechanism by which ZFP91 promotes production of IL-1β under physiological conditions and suggests that ZFP91 may be a promising therapeutic target for intervention in inflammatory, infectious and autoimmune-related diseases.
BACKGROUND AND PURPOSE: IL-1β is a cytokine of critical importance in inflammatory, infectious and autoimmune diseases. Zinc finger protein 91 (ZFP91) has been reported to be involved in multiple biological processes. Here, we identified a previously unknown role for ZFP91 in the production of biologically active IL-1β and investigated the underlying mechanisms of its effects. EXPERIMENTAL APPROACH: In vitro, the underlying mechanisms of ZFP91 at inhibiting the expression of IL-1β were investigated by ELISA, RT-PCR, Western blotting, immunoprecipitation and immunofluorescence assays. In vivo, colitis was induced by giving 4% dextran sulfate sodium (DSS) p.o. in drinking water for 5 days. Peritonitis was induced by injecting 700 μg alum i.p. for 12 h. KEY RESULTS:ZFP91 activated the non-canonical caspase-8 inflammasome, which resulted in robust IL-1β secretion. Using an immunoprecipitation assay and immunofluorescence assay, we found that ZFP91 promoted the assembly of the non-canonical caspase-8 inflammasome complex. Moreover, ZFP91 enhanced the activation of ERK, p38 MAPK and JNK in macrophages. In addition, our data demonstrate that the synthesis of pro-IL-1β is dependent on activation of these MAPK signalling pathways. In vivo experiments, the symptoms and colonic inflammation associated with DSS-induced colitis were ameliorated in mice deficient in ZFP91. Furthermore, the inflammation in alum-induced peritonitis was also attenuated in mice deficient in ZFP91. CONCLUSIONS AND IMPLICATIONS: Our research describes a mechanism by which ZFP91 promotes production of IL-1β under physiological conditions and suggests that ZFP91 may be a promising therapeutic target for intervention in inflammatory, infectious and autoimmune-related diseases.
Authors: Christian Bauer; Peter Duewell; Christine Mayer; Hans Anton Lehr; Katherine A Fitzgerald; Marc Dauer; Jurg Tschopp; Stefan Endres; Eicke Latz; Max Schnurr Journal: Gut Date: 2010-05-04 Impact factor: 23.059
Authors: Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2017-12 Impact factor: 8.739
Authors: Prajwal Gurung; Paras K Anand; R K Subbarao Malireddi; Lieselotte Vande Walle; Nina Van Opdenbosch; Christopher P Dillon; Ricardo Weinlich; Douglas R Green; Mohamed Lamkanfi; Thirumala-Devi Kanneganti Journal: J Immunol Date: 2014-01-22 Impact factor: 5.422
Authors: Wenchao Wu; Geoffrey M Nelson; Raphael Koch; Katherine A Donovan; Radosław P Nowak; Tayla B Heavican-Foral; Ajit J Nirmal; Huiyun Liu; Lei Yang; Jessica Duffy; Foster Powers; Kristen E Stevenson; Marcus Kenneth Jones; Samuel Y Ng; Gongwei Wu; Salvia Jain; Ran Xu; Sam Amaka; Christopher Trevisani; Nicholas L Donaldson; Patrick R Hagner; Laurence de Leval; Philippe Gaulard; Javeed Iqbal; Anjan Thakurta; Eric S Fischer; Karen Adelman; David M Weinstock Journal: Blood Date: 2022-03-31 Impact factor: 25.476
Authors: Ying Ye; Allison Gaudy; Peter Schafer; Michael Thomas; Daniel Weiss; Nianhang Chen; Liangang Liu; Yongjun Xue; Leon Carayannopoulos; Maria Palmisano Journal: Clin Pharmacol Drug Dev Date: 2020-09-23